Clinical Management of Pancreatic Cancer

From Diagnosis to Palliative Care

Häftad, Engelska, 2026

1 741 kr

Kommande

Beskrivning

Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care provides comprehensive guidance and support at every step of the pancreatic cancer journey, covering initial diagnosis and compassionate and holistic care. The book not only presents the latest advancements, including innovative surgical techniques, targeted therapies, radiotherapy approaches, and palliative care interventions, but also focuses on maintaining and improving patients' quality of life throughout their journey and incorporating palliative medicine and supportive care to alleviate symptoms and enhance overall well-being. Sections advocate for patient-centered care by emphasizing communication, shared decision-making, and tailored treatment approaches to individual needs and preferences.

In addition, the book raises awareness about pancreatic cancer, its challenges, and the importance of early detection while also dispelling misconceptions and offering hope through informed management strategies. It serves as a bridge between research and clinical practice, offering researchers a broader perspective while also equipping clinicians with a valuable resource that enhances their knowledge, decision-making, and patient care skills.

Provides the latest advancements, evidence-based approaches, and multidisciplinary insights to enhance knowledge and improve patient outcomes
Delivers a structured and detailed overview of the clinical management of pancreatic cancer
Presents insights on how to understand the complexities of diagnosis, treatment, and supportive care
Facilitates collaboration among different specialists, enabling them to make informed decisions and provide well-coordinated care that addresses the various aspects of the disease

Produktinformation

Utgivningsdatum:2026-12-01
Mått:191 x 235 x undefined mm
Vikt:450 g
Format:Häftad
Språk:Engelska
Antal sidor:300
Förlag:Elsevier Science
ISBN:9780443362934

Utforska kategorier

Mer om författaren

Takuji Okusaka is a prominent researcher known for his groundbreaking work in internal medicine, particularly in gastroenterology, hepatocellular carcinoma, oncology, and pancreatic cancer. His investigations span chemotherapy, clinical research phases, and survival rates. He explores the connections between hepatocellular carcinoma and radiology, unraveling complexities, while also delving into themes of weight loss, bioinformatics, and pancreatic diseases. With a focus on internal medicine, oncology, and gastroenterology, Okusaka's publications dominate these fields, marking him as a prolific and impactful contributor to medical research.Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly’s other responsibilities include Chair of the Institutional Review & Privacy Board (IRB) and Chair of the Continuing Medical Education committee at MSK. Nationally, Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the NCI Gastrointestinal Cancers Steering Committee (GISC) and serves in leadership roles in several advocacy organizations.

Innehållsförteckning

Section 1: Diagnosis1. Risk factors for pancreatic cancer2. Familiar risk factors and genetic testing for inherited mutation3. Screening/surveillance in high-risk population to detect pancreatic cancer4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer5. CT for diagnosis and staging of pancreatic cancer6. MRI/MRCP for diagnosis and staging of pancreatic cancer7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer8. Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer9. PET/CT for diagnosis, staging and follow-up10. Staging laparoscopy and laparoscopic ultrasound11. Germline and tumor/somatic genomic testing12. Staging for pancreatic cancerSection 2: Treatments for resectable and borderline resectable pancreatic cancer13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer14. Surgical resection for pancreatic cancer15. Minimally invasive pancreatic surgery for pancreatic cancer16. Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer17. Follow-up surveillance and management for patients after pancreatic surgerySection 3: Treatments for locally advanced and metastatic pancreatic cancer18. Treatment strategies for locally advanced pancreatic cancer19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer21. Second-line chemotherapy for advanced pancreatic cancer22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancerSection 4: Supportive and Palliative medicine for pancreatic cancer23. Stents for obstructive jaundice and gastric outlet obstruction24. Palliative surgery in advanced pancreatic cancer25. Pain control26. Managements for anxiety and depression27. Advance care planning for pancreatic cancer patients28. Venous thromboembolism in patients with pancreatic cancer29. Managements for ascites